AmerisourceBergen Corp. (NYSE:ABC) Chairman Steven H. Collis sold 21,350 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $98.58, for a total transaction of $2,104,683.00. Following the sale, the chairman now owns 287,925 shares of the company’s stock, valued at approximately $28,383,646.50. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
AmerisourceBergen Corp. (ABC) opened at $96.02 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.48 and a debt-to-equity ratio of 1.83. The firm has a market cap of $21,653.36, a P/E ratio of 51.90, a P/E/G ratio of 1.66 and a beta of 1.02. AmerisourceBergen Corp. has a 1 year low of $71.90 and a 1 year high of $106.27.
Large investors have recently bought and sold shares of the stock. First Merchants Corp boosted its position in shares of AmerisourceBergen by 160.5% during the 3rd quarter. First Merchants Corp now owns 27,342 shares of the company’s stock worth $2,262,000 after purchasing an additional 16,848 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its position in AmerisourceBergen by 23.3% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,459 shares of the company’s stock valued at $369,000 after buying an additional 842 shares during the period. Wedge Capital Management L L P NC boosted its position in AmerisourceBergen by 17.3% in the 3rd quarter. Wedge Capital Management L L P NC now owns 494,216 shares of the company’s stock valued at $40,896,000 after buying an additional 72,743 shares during the period. Achmea Investment Management B.V. boosted its position in AmerisourceBergen by 7.8% in the 2nd quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock valued at $2,770,000 after buying an additional 2,123 shares during the period. Finally, Burgundy Asset Management Ltd. boosted its position in AmerisourceBergen by 3.3% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock valued at $250,422,000 after buying an additional 84,163 shares during the period. 67.96% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have recently issued reports on ABC shares. Cowen upgraded shares of AmerisourceBergen from a “market perform” rating to an “outperform” rating in a report on Tuesday, October 10th. Zacks Investment Research upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Monday, October 16th. Needham & Company LLC set a $93.00 price target on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, October 24th. Mizuho set a $92.00 price target on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Tuesday, October 24th. Finally, Jefferies Group set a $85.00 price target on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Sunday, October 29th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $98.39.
TRADEMARK VIOLATION WARNING: “Steven H. Collis Sells 21,350 Shares of AmerisourceBergen Corp. (ABC) Stock” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/02/04/steven-h-collis-sells-21350-shares-of-amerisourcebergen-corp-abc-stock.html.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.